Discover the joys of crafting your very own DIY terrarium and transform your space into a green oasis! Whether this is your first time or you are a crafty botanical enthusiasts, this virtual workshop ...

RISE (Risk Assessment, Imaging, Surveillance, and Education) is a breast cancer screening program. Our experts will assess whether you’re at higher risk for breast cancer. If you are, we’ll make a ...

En esta información se explica qué son el síndrome de liberación de citocinas y el síndrome de neurotoxicidad. También se describen las causas, los síntomas y los tratamientos comunes de cada enfermed ...

New research from Memorial Sloan Kettering Cancer Center (MSK) finds improving intestinal metabolism may help treat chronic inflammation and prevent cancer; shows how breast cancer resistance is ...

Sayantan grew up in Elmont, NY and is studying biochemistry and bioinformatics at The University of Houston. After completing his bachelor's degree, he plans to pursue a PhD. He is interested in ...

En esta información se explican las pautas alimentarias (comida y bebida) que necesitará seguir después de su balón gástrico (gastroyeyunostomía) o el procedimiento de Whipple (duodenopancreatectomía) ...

When cancer spreads from a primary tumor to new sites throughout the body, it undergoes changes that increase its genetic complexity. A new study from researchers at Memorial Sloan Kettering Cancer ...

A clinical trial led by researchers at Memorial Sloan Kettering Cancer Center (MSK) has demonstrated a powerful new approach to help prevent cancer from coming back after treatment for stomach cancer, ...

On May 14, 2025, 14 new PhD scientists will officially receive their degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK). The graduates will receive their diplomas ...

CHICAGO — New results from a clinical trial led by Memorial Sloan Kettering Cancer Center (MSK), gastrointestinal oncologists Andrea Cercek, MD, and Luis Diaz Jr., MD, demonstrate how immunotherapy ...

For decades, cancers with mutations in the gene KRAS (KAY-ras) were considered “undruggable.” KRAS mutations are found in more than 20% of cancers. They are most common in lung cancer, pancreatic ...

MSK’s History of Stem Cell Research for Parkinson’s The phase 3 trial is the culmination of research going back 25 years, when Dr. Studer first came to MSK and began investigating embryonic stem cells ...